Detalles de la búsqueda
1.
Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial.
BMC Cancer
; 22(1): 960, 2022 Sep 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36071409
2.
A randomized, double-blind, placebo-controlled investigation of BCc1 nanomedicine effect on survival and quality of life in metastatic and non-metastatic gastric cancer patients.
J Nanobiotechnology
; 17(1): 52, 2019 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30971278
3.
Correction: Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial.
BMC Cancer
; 22(1): 1348, 2022 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36550442
4.
Pharmaceutical and clinical studies of celecoxib topical hydrogel for management of chemotherapy-induced hand-foot syndrome.
Naunyn Schmiedebergs Arch Pharmacol
; 396(7): 1571-1581, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36418469
5.
'Harlequin cells' in lymphocyte-variant hypereosinophilia.
EJHaem
; 3(4): 1390-1391, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36467787
Resultados
1 -
5
de 5
1
Próxima >
>>